Peptidergic nootropic therapy in cerebral palsy associated with epilepsy
Kholin AA, Zavadenko NN, Il Ina ES, Kolpakchi LM, Fedonyuk ID, Bembeeva RC, Esipova ES · 2017 · Zh Nevrol Psikhiatr Im S S Korsakova 117(9):37-42. PMID 29053119
What does this source report?
Adjunctive Cortexin with antiseizure medicines was associated with varied motor and seizure outcomes; one seizure aggravation was reported.
- Population and setting
- 84 children with cerebral palsy and epilepsy
- Evidence type
- Uncontrolled human report
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- No randomized untreated comparator described; do not infer seizure safety.
- Pediatric clinical findings do not establish enhancement or safety in healthy adults.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Recorded source-check date: 2026-09-29. This date does not imply a completed systematic review.
Cite and trace this record
Original source: Kholin AA, Zavadenko NN, Il Ina ES, Kolpakchi LM, Fedonyuk ID, Bembeeva RC, Esipova ES. Peptidergic nootropic therapy in cerebral palsy associated with epilepsy Zh Nevrol Psikhiatr Im S S Korsakova 117(9):37-42. PMID 29053119 2017.
Molekul research summary: https://molekul.io/research/bio-29053119. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry